Irving H. Fox
- Epidemiology top 0.2%
- Genetics top 0.1%
- Molecular Biology top 2%
- Immunology top 0.5%
- Surgery top 1%
- Co-authors
- William N. KelleyBrian G. FeaganAsit ParikhCatherine MilchWilliam J. SandbornBruce E. SandsSerap SankohJean‐Frédéric Colombel
- Topics
- Biochemical and Molecular Research (92 papers)Inflammatory Bowel Disease (45 papers)Cytomegalovirus and herpesvirus research (40 papers)
- Cited by
- PhysiologyGeneticsEpidemiology
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Irving H. Fox
190 papers receiving 11.5k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Epidemiology 5.9k
- Genetics 5.9k
- Molecular Biology 3.5k
- Immunology 2.6k
- Surgery 2.2k
Countries citing papers authored by Irving H. Fox
This map shows the geographic impact of Irving H. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irving H. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irving H. Fox more than expected).
Fields of papers citing papers by Irving H. Fox
This network shows the impact of papers produced by Irving H. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irving H. Fox. The network helps show where Irving H. Fox may publish in the future.
Co-authorship network of co-authors of Irving H. Fox
This figure shows the co-authorship network connecting the top 25 collaborators of Irving H. Fox. A scholar is included among the top collaborators of Irving H. Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irving H. Fox. Irving H. Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | The safety of vedolizumab for ulcerative colitis and Crohn's diseasebreakdown → | 563 |
| 2 | 38 | |
| 3 | 8 | |
| 4 | 9 | |
| 5 | Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failedbreakdown → | 531 |
| 6 | 70 | |
| 7 | Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitisbreakdown → | 2048 |
| 8 | 7 | |
| 9 | 182 | |
| 10 | Treatment of Ulcerative Colitis with a Humanized Antibody to the α 4 β 7 Integrinbreakdown → | 535 |
| 11 | 1 | |
| 12 | 46 | |
| 13 | 12 | |
| 14 | 1 | |
| 15 | 37 | |
| 16 | 15 | |
| 17 | Uric acid metabolism in patients receiving total parenteral nutrition (TPN). | 2 |
| 18 | Normal B-lymphocyte function in patients with Lesch-Nyhan syndrome and HGPRT deficiency. | 8 |
| 19 | Hypouricemia in disease: a study of different mechanisms. | 23 |
| 20 | 4 |
About Irving H. Fox
Irving H. Fox is a scholar working on Physiology, Clinical Biochemistry and Epidemiology, having authored 194 papers that have together received 12.1k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (92 papers), Inflammatory Bowel Disease (45 papers) and Cytomegalovirus and herpesvirus research (40 papers). The work is most often cited by research in Physiology (1.2k citations), Genetics (5.9k citations) and Epidemiology (5.9k citations). Irving H. Fox has collaborated with scholars based in United States, Canada and France. Frequent co-authors include William N. Kelley, Brian G. Feagan, Asit Parikh, Catherine Milch, William J. Sandborn, Bruce E. Sands, Serap Sankoh, Jean‐Frédéric Colombel, Paul Rutgeerts and Jing Xu. Their work appears in journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.